National Institutes of Health, National Human Genome Research Institute, NIH Chemical Genomics Center, Rockville, Maryland 20850, USA.
ChemMedChem. 2010 May 3;5(5):730-8. doi: 10.1002/cmdc.200900531.
Herein, we examine the potential of a nitrile-containing propionic acid moiety as an electrophile for covalent attack by the active-site cysteine residue of caspase 1. The syntheses of several cyanopropanate-containing small molecules based on the optimized peptidic scaffold of prodrug VX-765 were accomplished. These compounds were found to be potent inhibitors of caspase 1 (IC(50) values < or =1 nM). Examination of these novel small molecules against a caspase panel demonstrated an impressive degree of selectivity for caspase 1 inhibition over other caspase isozymes. Assessment of hydrolytic stability and selected ADME properties highlighted these agents as potentially useful tools for studying caspase 1 down-regulation in various settings, including in vivo analyses.
在此,我们研究了含腈基丙酸部分作为亲电试剂与半胱氨酸残基发生共价攻击的可能性,半胱氨酸残基位于半胱氨酸蛋白酶 1 的活性部位。基于前药 VX-765 的优化肽骨架,我们合成了几种含氰基丙酸盐的小分子。这些化合物被发现是强效的半胱氨酸蛋白酶 1 抑制剂(IC50值<或=1 nM)。对这些新型小分子进行的半胱氨酸蛋白酶谱分析表明,它们对半胱氨酸蛋白酶 1 的抑制具有很高的选择性,超过了其他半胱氨酸蛋白酶同工酶。对水解稳定性和部分 ADME 性质的评估突出了这些化合物作为研究各种环境(包括体内分析)中半胱氨酸蛋白酶 1 下调的潜在有用工具的特性。